scholarly journals SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

2019 ◽  
Vol 14 (10) ◽  
pp. 1839-1846 ◽  
Author(s):  
Corey J. Langer ◽  
Mary W. Redman ◽  
James L. Wade ◽  
Charu Aggarwal ◽  
Jeffrey D. Bradley ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase Ii ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Stage Iv ◽  
Squamous Cell Lung Cancer ◽  
Previously Treated

scholarly journals A phase II study of nedaplatin and nab-paclitaxel for patients with previously untreated advanced squamous cell lung cancer (KRSG1302)

2018 ◽  
Vol 29 ◽  
pp. viii517
Author(s):  
T. Sugiyama ◽  
T. Kasai ◽  
N. Koyama ◽  
K. Kobayashi ◽  
E. Hoshi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase Ii ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Squamous Cell Lung Cancer

scholarly journals Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer

2019 ◽  
Vol 10 (9) ◽  
pp. 1764-1769
Author(s):  
Hirokazu Taniguchi ◽  
Hiroyuki Yamaguchi ◽  
Yosuke Dotsu ◽  
Midori Shimada ◽  
Hiroshi Gyotoku ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase Ii ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Squamous Cell Lung Cancer ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer

JAMA Oncology ◽  
2021 ◽  
Author(s):  
Scott N. Gettinger ◽  
Mary W. Redman ◽  
Lyudmila Bazhenova ◽  
Fred R. Hirsch ◽  
Philip C. Mack ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Stage Iv ◽  
Squamous Cell Lung Cancer ◽  
Previously Treated Patients ◽  
Previously Treated

scholarly journals A Phase II Study of Tailored-dose S-1 Plus Carboplatin Followed by Maintenance S-1 for Advanced Squamous Cell Lung Cancer: OSAKA-LCSG 1102

2019 ◽  
Vol 58 (10) ◽  
pp. 1405-1410 ◽  
Author(s):  
Takashi Yokoi ◽  
Seigo Minami ◽  
Takayuki Shiroyama ◽  
Taro Koba ◽  
Yoshitaro Torii ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase Ii ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Squamous Cell Lung Cancer

scholarly journals Phase II study of nedaplatin plus amrubicin in patients with untreated, advanced or relapsed squamous cell lung cancer

2018 ◽  
Vol 29 ◽  
pp. ix154
Author(s):  
T. Suyama ◽  
H. Taniguchi ◽  
T. Ikeda ◽  
H. Yamaguchi ◽  
T. Kitazaki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase Ii ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Squamous Cell Lung Cancer

scholarly journals Phase II Study of Tailored Dose S-1 Plus Carboplatin Followed by S-1 for Advanced Squamous Cell Lung Cancer

2013 ◽  
Vol 24 ◽  
pp. ix62
Author(s):  
N. Yuh ◽  
K. Komuta ◽  
T. Yokoi ◽  
S. Yamamoto ◽  
S. Minami ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase Ii ◽  
Squamous Cell ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Squamous Cell Lung Cancer
Sign in / Sign up

Export Citation Format

Share Document